A Comprehensive Guide to GMP Risk Assessment of ADC Drugs from the Perspective of Drug Supervision
Click the blue text to follow us This article is based on the paper “Research on Key GMP Inspection Points in the Production of Antibody-Drug Conjugates” (Author: Ma Yansong, et al.; National Medical Products Administration Center for Food and Drug Review) published in 2025, systematically outlining the entire GMP regulatory chain of ADC drugs from … Read more